ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogsBruce W. Keene, Masami Uechi, Clarke E. Atkins et al.|Journal of Veterinary Internal Medicine|2019Cited by 810
Guidelines for the Diagnosis and Treatment of Canine Chronic Valvular Heart DiseaseClarke E. Atkins, Rebecca L. Stepien, Virginia Luis Fuentes et al.|Journal of Veterinary Internal Medicine|2009Cited by 545
Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study—A Randomized Clinical TrialAdrian Boswood, Philip Watson, Jens Häggström et al.|Journal of Veterinary Internal Medicine|2016Cited by 318
Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in catsPhilip R. Fox, Daniel F. Hogan, Mark A. Oyama et al.|Journal of Veterinary Cardiology|2009Cited by 113
Cardiorespiratory effects of acepromazine maleate and buprenorphine hydrochloride in clinically normal dogsRebecca L. Stepien, William W. Muir, John D. Bonagura et al.|American Journal of Veterinary Research|1995Cited by 104